Toll Free: 1-888-928-9744

Congestive Heart Failure (Heart Failure) Global Clinical Trials Review, H1, 2016

Published: Mar 31, 2016 | Pages: 910 | Publisher: GlobalData | Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

Congestive Heart Failure (Heart Failure) Global Clinical Trials Review, H1, 2016

Summary

GlobalData's clinical trial report, 
 Table of Contents
1 Table of Contents 2 List of Tables 3 List of Figures 4 Report Guidance 5 Clinical Trials by Region 6 Clinical Trials and Average Enrollment by Country 7 Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10 Top Five Countries Contributing to Clinical Trials in Europe 11 Top Countries Contributing to Clinical Trials in North America 12 Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13 Top Five Countries Contributing to Clinical Trials in Central and South America 14 Clinical Trials by G7 Countries: Proportion of Congestive Heart Failure (Heart Failure) to Cardiovascular Clinical Trials 15 Clinical Trials by Phase in G7 Countries 16 Clinical Trials in G7 Countries by Trial Status 17 Clinical Trials by E7 Countries: Proportion of Congestive Heart Failure (Heart Failure) to Cardiovascular Clinical Trials 18 Clinical Trials by Phase in E7 Countries 19 Clinical Trials in E7 Countries by Trial Status 20 Clinical Trials by Phase 21 In Progress Trials by Phase 22 Clinical Trials by Trial Status 23 Clinical Trials by End Point Status 24 Subjects Recruited Over a Period of Time 25 Clinical Trials by Sponsor Type 26 Prominent Sponsors 27 Top Companies Participating in Congestive Heart Failure (Heart Failure) Therapeutics Clinical Trials 28 Prominent Drugs 30 Latest Clinical Trials News on Congestive Heart Failure (Heart Failure) 31 Mar 28, 2016: The Medicines Company Announces Participation at 2016 American College of Cardiology Scientific Sessions in Chicago 31 Mar 10, 2016: Vericel Announces Positive Top-Line Results From Phase 2b ixCELL-DCM Clinical Trial of Ixmyelocel-T in Patients With Heart Failure Due to Ischemic Dilated Cardiomyopathy 31 Feb 01, 2016: Mast Therapeutics' AIR001 Selected By The Heart Failure Clinical Research Network For Evaluation In A 100-Patient Multicenter Phase 2 Study 32 Clinical Trial Profile Snapshots 34 Appendix 907 Abbreviations 907 Definitions 907 Research Methodology 908 Secondary Research 908 About GlobalData 909 Contact Us 909 Disclaimer 909 Source 910
List of Tables
Congestive Heart Failure (Heart Failure) Therapeutics, Global, Clinical Trials by Region, 2016* 6 Congestive Heart Failure (Heart Failure) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 8 Congestive Heart Failure (Heart Failure) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 9 Congestive Heart Failure (Heart Failure) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016* 10 Congestive Heart Failure (Heart Failure) Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 11 Congestive Heart Failure (Heart Failure) Therapeutics Clinical Trials, North America, Top Countries, 2016* 12 Congestive Heart Failure (Heart Failure) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2016* 13 Congestive Heart Failure (Heart Failure) Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2016* 14 Proportion of Congestive Heart Failure (Heart Failure) to Cardiovascular Clinical Trials, G7 Countries (%), 2016* 15 Congestive Heart Failure (Heart Failure) Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 16 Congestive Heart Failure (Heart Failure) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 17 Proportion of Congestive Heart Failure (Heart Failure) to Cardiovascular Clinical Trials, E7 Countries (%), 2016* 18 Congestive Heart Failure (Heart Failure) Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 19 Congestive Heart Failure (Heart Failure) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 20 Congestive Heart Failure (Heart Failure) Therapeutics, Global, Clinical Trials by Phase, 2016* 21 Congestive Heart Failure (Heart Failure) Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 22 Congestive Heart Failure (Heart Failure) Therapeutics, Global, Clinical Trials by Trial Status, 2016* 23 Congestive Heart Failure (Heart Failure) Therapeutics Clinical Trials, Global, by End Point Status, 2016* 24 Congestive Heart Failure (Heart Failure) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 25 Congestive Heart Failure (Heart Failure) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 26 Congestive Heart Failure (Heart Failure) Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 27 Congestive Heart Failure (Heart Failure) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 29 Congestive Heart Failure (Heart Failure) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 30


List of Figures
Congestive Heart Failure (Heart Failure) Therapeutics, Global, Clinical Trials by Region (%), 2016* 6 Congestive Heart Failure (Heart Failure) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7 Congestive Heart Failure (Heart Failure) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 9 Congestive Heart Failure (Heart Failure) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016* 10 Congestive Heart Failure (Heart Failure) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 11 Congestive Heart Failure (Heart Failure) Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 12 Congestive Heart Failure (Heart Failure) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2016* 13 Congestive Heart Failure (Heart Failure) Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2016* 14 Proportion of Congestive Heart Failure (Heart Failure) to Cardiovascular Clinical Trials, G7 Countries (%), 2016* 15 Congestive Heart Failure (Heart Failure) Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 16 Congestive Heart Failure (Heart Failure) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 17 Proportion of Congestive Heart Failure (Heart Failure) to Cardiovascular Clinical Trials, E7 Countries (%), 2016* 18 Congestive Heart Failure (Heart Failure) Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 19 Congestive Heart Failure (Heart Failure) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 20 Congestive Heart Failure (Heart Failure) Therapeutics, Global, Clinical Trials by Phase (%), 2016* 21 Congestive Heart Failure (Heart Failure) Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 22 Congestive Heart Failure (Heart Failure) Therapeutics, Global, Clinical Trials by Trial Status, 2016* 23 Congestive Heart Failure (Heart Failure) Therapeutics Clinical Trials, Global, by End Point Status, 2016* 24 Congestive Heart Failure (Heart Failure) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 25 Congestive Heart Failure (Heart Failure) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 26 Congestive Heart Failure (Heart Failure) Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 27 Congestive Heart Failure (Heart Failure) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 28 Congestive Heart Failure (Heart Failure) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 30 GlobalData Methodology 908

To request a free sample copy of this report, please complete the form below.

This website is secure and your personal details are safe. Privacy policy

Global Bio polyethylene terephthalate (PET) market size is likely to be valued at USD 12.6 billion by 2020; as per a new research report by Radiant Insights, Inc. Growing preference of biopolymers in numerous applications coupled with favorable gover

Read More...

Global heat transfer fluids market size is likely to be valued at USD 3.7 billion by 2020; as per a new research report by Radiant Insights, Inc. Increasing demand for for heat recovery management in industries such as metal processing, pharmaceutica

Read More...

Global CoQ10 market size was 687.2 tons in 2014 and is expected to reach 1,168 tons by 2020, growing at a CAGR of 9.2% from 2014 to 2020, according to a new study by Radiant Insights, Inc. Increasing scope in personal care applications is expected to

Read More...

Global agricultural films market size is anticipated to reach USD 10.5 billion by 2020, as per a new research report by Radiant Insights, Inc. Increasing need to raise agricultural productivity, in order to meet surplus demand by growing population i

Read More...

Global outsourced customer care services market is projected to reach USD 84.7 billion by 2020, as per a new research report by Radiant Insights, Inc. Swelling need for interaction through non-voice channels is estimated to boost global demand over t

Read More...
Choose License Type
Single User - US $2500
Multi User - US $5000
Why Choose Us

24/5 Research support

Get your queries resolved from an industry expert. Request for a free product review before report purchase.

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Quality assurance

A testimonial for service excellence represented in the form of BBB "A" Accreditation.

Information security

Your personal and confidential information is safe and secure.

verify